The use of synthetic long peptides for induction and T-cell responses has shown superior effects in contrast to minimal peptide sequences in both mice and humans, furthermore synthetic long peptide has been shown to be efficiently processed and presented to both CD4 and CD8 T-cells of the immune system. Also, long-peptides have the advantage to enable presentation of several different T-cell epitopes dependent on the patients' HLA type. Thus, the choice of long peptides will minimize the impact of patients HLA type, and therefore in the present study allow inclusion of participants without prior selection based on HLA expression.